The 2021 Antimicrobial Resistance Benchmark compares how pharmaceutical companies are tackling this crisis. This independent report covers R&D, responsible manufacturing, access and stewardship.
Thoughts?
Have you found the Impact Toolkit useful? We encourage you to share any feedback with us.